CRISPR construct designed to result in activation of a target gene when combined with a source of nuclease-dead Cas9 fused to a transcriptional activator domain. Constitutively expresses two sgRNAs, both of which target sequence upstream of the transcription start sites of α-Man-Ib and CG11876.
